Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Endomagnetics Appoints Strategic Distributor

Complete SentiMag system
Complete SentiMag system

Abstract:
Endomagnetics, the company developing a portfolio of products to improve the standard of breast cancer management, has announced it has signed a distribution agreement with Sysmex Europe GmbH, a subsidiary of global healthcare company Sysmex Corporation. Sysmex has the exclusive right to provide sales and support for Endomagnetics' SentiMag® system across the EMEA region. This is Endomagnetics' first multi-region agreement, and it promises to extend widely the clinical use of the company's technology.

Endomagnetics Appoints Strategic Distributor

Cambridge, UK | Posted on March 1st, 2013

The SentiMag® system is used as part of the current standard sentinel lymph node (SLNB) technique, used by surgeons to monitor the spread of cancer and to plan interventions. Unlike the present system, Endomagnetics' technology can be used by surgeons as part of an efficient workflow, and does not require specialist technicians to store and manage radioisotopes. Patients are spared the anxiety of radioactivity and the possible need to attend multiple clinics. The system consists of the highly sensitive SentiMag® instrument and its associated tracer, Sienna+®. The system is currently in use in eight countries across the EU: UK, Germany, Poland, France, Italy, Belgium, Holland, and Switzerland.

Dr Marc Thill, Head of the Department of Gynaecology and Obstetrics and the Breast Cancer Centre at Agaplesion Markus Hospital, Frankfurt reported: "After working with the SentiMag® technique in my daily routine for the past few months, I have concluded that this technique is an easy-to-use approach for performing SLNB without radioisotopes or any time-consuming pre-operative preparation of the patient. For that reason it may ultimately replace the standard of care."

Endomagnetics cited Sysmex's strong history of customer support, compatible product pipeline and focus on healthcare innovation in developing this strategic relationship. Sysmex is the global market leader in haematology, and has built on its successes in diagnostics to innovate in the life science field. In particular, Sysmex has developed a molecular diagnostics assay called OSNA (One Step Nucleic Acid Amplification). This assay enables complete lymph nodes to be analysed quickly, and is used routinely for analysing sentinel lymph nodes for breast cancer in about 200 hospitals across Europe.

"SentiMag® offers hospitals and clinics a powerful, efficient new way of locating lymph nodes to verify the spread of breast cancer," said Dr Michael Schaefer, Managing Director of Sysmex Europe. "It is an excellent strategic fit with our product portfolio and an ideal complement to our OSNA system. Our sales teams across the EU have received very positive feedback from customers."

CEO of Endomagnetics Dr Eric Mayes commented: "We are extremely pleased with initial customer feedback, and partnering with a group as strong as Sysmex gives us the geographic scope and customer support we need to really make an impact. We have been extremely impressed with the enthusiasm of the Sysmex team in supporting our joint product launch."

####

About Endomagnetics
Endomagnetics was founded to solve cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology. Endomagnetics is developing a portfolio of medical device products based on a patented ability to detect magnetic materials in the human body with exceptional sensitivity. The technology was originally developed at University College London and the University of Houston.

The company’s first product, the SentiMag®, is an ultrasensitive hand-held probe for tracking injected Sienna+® nanoscale magnetic materials in the human body. Cambridge, UK-based Endomagnetics is in the process of delivering its technology to global markets. For more information please visit www.endomagnetics.com.

About Sysmex

Sysmex is a global group, with more than 40 overseas subsidiaries conducting business in more than 170 countries. It develops, produces and sells instruments, reagents and software used in in-vitro diagnostics in hospitals and testing centres. In the global market, Sysmex ranks in the top 10 in diagnostics. In haematology, it holds the top share of the global market.

Overseas business development has been a focus for Sysmex since it was founded. It operates R&D, production, sales and customer support facilities around the world to ensure products and services are delivered that meet the needs of the customer in each region. Principal clinical areas of activity are: Haematology, Haemostasis, Immunochemistry, Urinalysis, Clinical Chemistry and Life Science.

www.sysmex.com

For more information, please click here

Contacts:
Editorial contact:
Terry Nicklin
KeynotePR Ltd
Tel: +44 (0)7923 540695


Company contact:
Dr Eric Mayes, CEO
Endomagnetics Ltd
Tel: +44 (0)1223 652540

Copyright © Endomagnetics

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Shining rings: A new material emits white light when exposed to electricity: New synthetic approach could spark development of other dynamic materials July 24th, 2017

Ultrathin device harvests electricity from human motion July 23rd, 2017

The July 23 close fly-by of asteroid 2017 BS5 is explored in a Q&A with Dr. John S. Lewis, chief scientist at Deep Space Industries July 23rd, 2017

Scientists announce the quest for high-index materials: All-dielectric nanophotonics: The quest for better materials and fabrication techniques July 22nd, 2017

Nanomedicine

Shining rings: A new material emits white light when exposed to electricity: New synthetic approach could spark development of other dynamic materials July 24th, 2017

Scientists announce the quest for high-index materials: All-dielectric nanophotonics: The quest for better materials and fabrication techniques July 22nd, 2017

Probiotics: Novel biosynthetic tool to develop metallic nanoparticles: This research article by Dr. Nida Akhtar et al has been published in Recent Patents on Drug Delivery & Formulation, Volume 11, Issue 1, 2017 July 20th, 2017

Semiliquid chains pulled out of a sea of microparticles July 20th, 2017

Announcements

Shining rings: A new material emits white light when exposed to electricity: New synthetic approach could spark development of other dynamic materials July 24th, 2017

Ultrathin device harvests electricity from human motion July 23rd, 2017

The July 23 close fly-by of asteroid 2017 BS5 is explored in a Q&A with Dr. John S. Lewis, chief scientist at Deep Space Industries July 23rd, 2017

Scientists announce the quest for high-index materials: All-dielectric nanophotonics: The quest for better materials and fabrication techniques July 22nd, 2017

Alliances/Trade associations/Partnerships/Distributorships

GLOBALFOUNDRIES and VeriSilicon To Enable Single-Chip Solution for Next-Gen IoT Networks: Integrated solution leverages GF’s 22FDX® technology to decrease power, area, and cost for NB-IoT and LTE-M applications July 14th, 2017

Advanced Nanomechanical Characterization Centre Open in India: Nanomechanics, Inc. announces the establishment of the joint technology development center in Hyderabad, India July 5th, 2017

U.S. Air Force Research Lab Taps IBM to Build Brain-Inspired AI Supercomputing System: Equal to 64 million neurons, new neurosynaptic supercomputing system will power complex AI tasks at unprecedented speed and energy efficiency June 23rd, 2017

Cambridge Nanotherm partners with Inabata for global sales and distribution June 20th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project